InvestSMART

SomnoMed Limited (ASX: SOM) - Announcements

Current share price for SOM : $0.235 0.015 (6%)+

ASX company news and announcements for SomnoMed Limited (SOM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All SomnoMed Limited (SOM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than SomnoMed Limited (SOM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for SomnoMed Limited (SOM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$52 US Medicare PDAC registration approved 26 Sep 2011 10:19AM $1.120 $0.235 fallen by 79.02%
$52 Investor presentation 29 Aug 2011 9:37AM $1.200 $0.235 fallen by 80.42%
$52 Preliminary Final Report 25 Aug 2011 2:55PM $1.120 $0.235 fallen by 79.02%
$52 Appendix 4C - quarterly 27 Jul 2011 2:03PM $1.400 $0.235 fallen by 83.21%
$52 Appendix 4C - quarterly 29 Apr 2011 1:01PM $1.345 $0.235 fallen by 82.53%
$52 SomnoMed posts new record in Q3 29 Apr 2011 1:01PM $1.300 $0.235 fallen by 81.92%
$52 Half Yearly Report and Accounts 24 Feb 2011 2:54PM $1.300 $0.235 fallen by 81.92%
$52 CEO transfers to US 7 Feb 2011 12:47PM $0.930 $0.235 fallen by 74.73%
$52 Quarterly Cashflow Report 27 Jan 2011 1:48PM $0.930 $0.235 fallen by 74.73%
$52 SomnoMed reports solid growth and stronger profits 28 Oct 2010 12:24PM $1.040 $0.235 fallen by 77.40%
$52 Appendix 4C - quarterly 28 Oct 2010 12:22PM $1.050 $0.235 fallen by 77.62%
$52 SomnoMed Announces Sleep Apnea Management Program 20 Oct 2010 10:35AM $1.000 $0.235 fallen by 76.50%
$52 Preliminary Final Report 26 Aug 2010 11:10AM $0.880 $0.235 fallen by 73.30%
$52 Appendix 4C - quarterly 26 Jul 2010 11:30AM $0.810 $0.235 fallen by 70.99%
$52 SomnoMed finishes year with record quarter 26 Jul 2010 11:30AM $0.800 $0.235 fallen by 70.63%
$52 Somnomed expands business and operations in Europe 2 Jul 2010 10:26AM $0.795 $0.235 fallen by 70.44%
$52 Somnomed introduces new Medical product 29 Jun 2010 10:36AM $0.795 $0.235 fallen by 70.44%
$52 Appendix 4C - quarterly 29 Apr 2010 10:02AM $0.960 $0.235 fallen by 75.52%
$52 Half Yearly Report and Accounts 18 Feb 2010 11:12AM $0.950 $0.235 fallen by 75.26%
$52 Quarterly Cashflow Report 27 Jan 2010 9:56AM $0.855 $0.235 fallen by 72.51%
$52 SomnoMed Accelerates Growth beyond Forecasts 27 Jan 2010 9:49AM $0.850 $0.235 fallen by 72.35%
$52 Launch of new product line to treat Sleep Bruxism 19 Jan 2010 9:22AM $0.830 $0.235 fallen by 71.69%
$52 Somnomed enters strategic partnerships in the USA 9 Nov 2009 10:24AM $0.052 $0.235 risen by 351.92%
$52 Appendix 4C - quarterly 26 Oct 2009 9:51AM $0.039 $0.235 risen by 502.56%
$52 Somnomed now profitable 26 Oct 2009 9:50AM $0.039 $0.235 risen by 502.56%

626 - 650 of 698 results

Page 26 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.